Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)

项目摘要 范德比尔特-埃默里-康奈尔-杜克财团（VECDor）带来了大量的补充专业知识， Fogarty全球健康研究员计划的经验丰富的机构。范德比尔特全球研究所 健康（VIGH）曾担任福格蒂国际临床研究学者和研究员（FICRS-F） 自2007年以来，计划支持中心与87所合作机构合作，培养了419名竞争性选择的学生 来自美国和27个低收入和中等收入国家（LMIC）的博士前和博士后学员。主题 包括传染病，癌症，心脏和肺部疾病，中风，糖尿病，营养，行为和 精神健康问题（包括药物滥用）、妇女和儿童健康、眼科疾病、口腔 健康、神经学和动物-人类健康。VECDor经验丰富的全球健康导师已经 在美国和LMIC合作伙伴机构一起工作，被选为多样化，资金充足的研究地点， 非洲（肯尼亚、赞比亚、坦桑尼亚、卢旺达）、亚洲（印度、中国、越南）、拉丁美洲（巴西、墨西哥）、 和加勒比（海地）。使用高效的支持中心，最大限度地将资金用于 研究培训，并利用多种来源的财政和实物共同资助，我们将与更多的 超过68个T32和其他NIH资助的培训项目，并与少数民族机构合作伙伴选择， 部署80至100名美国和LMIC受训人员，他们具有出色的研究职业前景。VECDor将 在整个联盟内实施战略指导和学员支持计划，包括 实地部署前的准备阶段，并在研究年结束后继续进行，以确保 最高质量的研究出版物和科学会议演示文稿，以及最大限度地提高学员的成功率， 获得研究和职业发展赠款。研究主题将涉及所有主题， 学员和NIH研究所和中心感兴趣的地理区域，强调沟通 和非传染性疾病。我们将通过长期监测记录该计划的影响， 一个评估（M&E）计划，使用FIC的CareerTrac跟踪所有研究员的职业方向和产出 系统，例如，未来的就业，K赠款，研究资助，科学演示和出版物。我们将 进一步完善我们现有的基于网络的工具，以分享知识，促进地方和全球网络， 加强和维持全球卫生研究员和校友的临床研究技能。我们促成了 大量的机构和基于站点的共同资助，以利用NIH资源。VECDor是建立在共同的 尊重我们的美国和全球合作伙伴以及我们在研究创新和指导方面的集体记录。 结合我们最近在研究培训计划管理方面的丰富经验， 全球重大疾病的资金基础，著名的国际研究培训合作伙伴， 网站，并加强机构共同资助的承诺，VECDor将继续培养的关键成员， 正如我们在现有的FICRS-F计划中所做的那样，我们正在努力培养21世纪世纪的全球卫生研究队伍。

PROJECT SUMMARY The Vanderbilt-Emory-Cornell-Duke Consortium (VECDor) brings the substantial and complementary expertise of experienced institutions to the Fogarty Global Health Fellows Program. The Vanderbilt Institute for Global Health (VIGH) has served as the Fogarty International Clinical Research Scholars and Fellows (FICRS-F) Program Support Center since 2007, working with 87 partner institutions to nurture 419 competitively chosen pre- and postdoctoral trainees from the US and from 27 low- and middle-income countries (LMICs). Topics have included infectious diseases, cancer, heart and lung disease, stroke, diabetes, nutrition, behavioral and mental health issues (including substance abuse), women's and children's health, ophthalmic disease, oral health, neurology, and animal-human health. VECDor's highly experienced global health mentors are already working together in the US and LMIC partner institutions, selected as diverse, well-funded research sites in Africa (Kenya, Zambia, Tanzania, Rwanda), Asia (India, China, Vietnam), Latin America (Brazil, Mexico), and the Caribbean (Haiti). Using a highly efficient support center that maximizes the direction of funds to research training, and leveraging multiple sources of financial and in-kind co-funding, we will link with more than 68 T32 and other NIH-funded training programs and with minority institution partners to select and deploy 80 to 100 US and LMIC trainees with outstanding promise for research careers. VECDor will implement a strategic mentoring and trainee support plan across the consortium, including a substantial preparation phase prior to field deployment and continuing after the research year is completed, to ensure the highest quality research publications and scientific meeting presentations, and maximum trainee success in obtaining research and career development grants. Research themes will address all topic and geographical areas of interest to trainees and NIH Institutes and Centers, emphasizing both communicable and non-communicable diseases. We will document the Program's impact through a long-term monitoring and evaluation (M&E) plan that tracks the career directions and outputs of all Fellows, using FIC's CareerTrac system, e.g., future employment, K grants, research grants, scientific presentations, and publications. We will further refine our existing web-based tools to share knowledge, foster local and global networking, and strengthen and sustain clinical research skills among global health fellows and alumni. We have brokered substantial institutional and site-based co-funding to leverage NIH resources. VECDor is built on the mutual respect of our US and global partners and our collective track record of research innovation and mentorship. Combining our extensive recent experience in research training program management, robust research funding bases in major diseases of global significance, renowned international research training partners and sites, and enhanced institutional co-funding commitments, VECDor will continue to nurture key members of the global health research workforce of the 21st century, as we have done within the incumbent FICRS-F program.